Sodium-glucose co-transporter 2 (SGLT2) inhibitor: comparing trial data and real-world use

Eitemau Tebyg

• Sodium-glucose co-transporter-2 (SGLT2) inhibitors: comparing trial and real world use (study protocol)
  gan: McGovern, A, et al.
  Cyhoeddwyd: (2017)
• Disparities in prescribing of sodium-glucose co-transporter-2 (SGLT2) inhibitors and DPP-4 inhibitors in people with Type 2 diabetes and chronic kidney disease (CKD)
  gan: Shah, S, et al.
  Cyhoeddwyd: (2018)
• Sodium-glucose co-transporter-2 inhibitor cardiovascular outcome trials and generalizability to English primary care
  gan: Hinton, W, et al.
  Cyhoeddwyd: (2020)
• How generalizable are cardiovascular outcome trials of sodium-glucose co-transporter-2 inhibitors? A national database study: study protocol
  gan: Hinton, W, et al.
  Cyhoeddwyd: (2019)
• Does renal function or heart failure diagnosis affect primary care prescribing for sodium-Glucose co-transporter 2 inhibitors in type 2 diabetes?
  gan: Hinton, W, et al.
  Cyhoeddwyd: (2020)